GIN on the Rocks (GOTR)

GOTR is the Greater Intermountain Node's (GIN) monthly Research Discussion Series that highlights the exceptional addiction related research happening in the Greater Intermountain Community. Additionally, GOTR allows for interactive discussion between speakers and attendees to collobarate and share ideas about study expansion and insight. 

*The series title is a fun play on words about the popular drink and our node name - but more importantly we are highlighting the beautiful Rocky Mountain views and famous Utah hiking trails just steps away from our offices!

UPCOMING GOTR:

Our GOTR 2021 line up is currently being organized! Exciting things are underway for 2021, stay tuned!

PREVIOUS GOTR

2020:

January 2020

Subthreshold Opioid Use Disorder Prevention (STOP) Trial (CTN -0101)

Adam Gordon, MD MPH FACP DFASAM 

Watch Now
February 2020 Canceled & Rescheduled --
March 2020

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a pragmatic randomized trial comparing two buprenorphine formulations

Kristi Carlston; Jerry Cochran, PhD MSW; Jasmin Charles, PA-C MPAS; Jade Hill, MPH; and Marcela Smid, MD MA MS

Watch Now
April - August 2020 Postponed in safety response to the COVID-19 pandemic --
September 2020

Using machine learning to predict opioid overdose and opioid use disorder

Wei-Hsuan Jenny Lo-Ciganic, MS PHARM MS PhD

October 2020

Improving Mental Health and Substance Use Outcomes for Homeless Veterans through Tailored Services Design

Audrey Jones, PhD

November 2020

A Behavioral Health and Harm Reduction Intervention for Chronic Pain Patients at Risk for Opioid Misuse; and The Impact of Social Distancing on Chronic Pain Patients During the COVID-19 Pandemic

Valerie Hruschak, PhD

December 2020

Enhancing POUD Care in Rural Communities

Shayla Archer, MS; Jacob Baylis, MPH; Ary Bryan, MSW; and Mitchell Garets, BSW

2019:

July 2019

Overview of the Greater Intermountain Node

Adam Gordon, MD MPH FACP DFASAM 

--

August 2019

A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration  

Adam Gordon, MD MPH FACP DFASAM 

--

September 2019

Validation of a Community Pharmacy-based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN) (NIH HEAL Initiative)

Jerry Cochran, PhD MSW

--

October 2019

Emergency Department-INitiated BupreNOrphine VAlidaTIONetwork Trial (CTN 0099)

Peter Taillac, MD

Watch Now

November 2019

Canceled & Rescheduled --
December 2019

Mindfulness Interventions Research

Eric Garland, PhD

Watch Now